Evidence map›Paper›PMID 38634211›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Palm-Sized Lab-In-A-Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection.

Ziyue Li, Shuo Zhang, Jiongyu Zhang, Lori Avery, David Banach, Hui Zhao, Changchun Liu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. CRISPR-Programmable Nanoparticle Transport in Salt-Gated Porous Media for Visual DNA Detection.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Palm-Sized Lab-In-A-Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ziyue LiDepartment of Biomedical Engineering, University of Connecticut Health Center, Farmington, Connecticut, 06030, USA.
Shuo ZhangDepartment of Biomedical Engineering, University of Connecticut Health Center, Farmington, Connecticut, 06030, USA.
Jiongyu ZhangDepartment of Biomedical Engineering, University of Connecticut Health Center, Farmington, Connecticut, 06030, USA.
Lori AveryDepartment of Pathology and Laboratory Medicine, University of Connecticut Health Center, Farmington, Connecticut, 06030, USA.
David BanachDepartment of Medicine, Division of Infectious Diseases, University of Connecticut Health Center, Farmington, Connecticut, 06030, USA.
Hui ZhaoDepartment of Mechanical Engineering, University of Nevada, Las Vegas, Nevada, 89154, USA.
Changchun LiuDepartment of Biomedical Engineering, University of Connecticut Health Center, Farmington, Connecticut, 06030, USA.ORCID 0000-0002-4931-986X

Funding

Asymmetric CRISPR Approach for Nucleic Acid QuantificationR01EB023607 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI Changchun Liu · 2017 to 2026
$2.4M
Self-Powered Sample Concentrating and CRISPR-based Biosensing for Moile HIV-1 RNA DetectionR33AI154642 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LIU, CHANGCHUN · 2023 to 2024
$1.6M
Durable Self-cleaning Fluorinated Graphene Oxide Coated N95 RespiratorsR21OH012194 · OH · UNIVERSITY OF NEVADA LAS VEGAS · PI ZHAO, HUI · 2021 to 2022
$367k
NIAID NIH HHS R33 AI154642NIBIB NIH HHS R01 EB023607NIH HHS R01 EB023607NIH HHS R21OH012194NIH HHS R33AI154642NIOSH CDC HHS R21 OH012194
6 · The paper itself

Abstract

Simple, sensitive, and accurate molecular diagnostics are critical for preventing rapid spread of infection and initiating early treatment of diseases. However, current molecular detection methods typically rely on extensive nucleic acid sample preparation and expensive instrumentation. Here, a simple, fully integrated, lab-in-a-magnetofluidic tube (LIAMT) platform is presented for "sample-to-result" molecular detection of virus. By leveraging magnetofluidic transport of micro/nano magnetic beads, the LIAMT device integrates viral lysis, nucleic acid extraction, isothermal amplification, and CRISPR detection within a single engineered microcentrifuge tube. To enable point-of-care molecular diagnostics, a palm-sized processor is developed for magnetofluidic separation, nucleic acid amplification, and visual fluorescence detection. The LIAMT platform is applied to detect SARS-CoV-2 and HIV viruses, achieving a detection sensitivity of 73.4 and 63.9 copies µL

Indexed as

COVID-19Lab-On-A-Chip DevicesNucleic Acid Amplification TechniquesSARS-CoV-2Equipment DesignHIVHIV InfectionsHumansMolecular Diagnostic TechniquesPoint-of-Care SystemsSensitivity and SpecificityCRISPR‐based nucleic acid detectionHIV detectionmagnetofluidic separationmicrofluidic technologySARS‐CoV‐2 detection

Identifiers

PMID38634211
PMCPMC11187901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.